Lenalidomide - CAS 191732-72-6
Catalog number: B0084-461959
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C13H13N3O3
Molecular Weight:
259.265
COA:
Inquire
Targets:
PROTAC | TNF-alpha
Description:
Lenalidomide is an analog of thalidomide, a TNF-α production inhibitor. Lenalidomide can be utilized in PROTAC as an E3 ligase ligand for targeting cereblon, inducing ubiquitination and degradation of casein kinase (CK) 1α by E3 ubiquitin ligase. Lenalidomide has been developed for the treatment of multiple myeloma and myelodysplastic syndromes (MDS).
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-461959 25 g $298 In stock
Bulk Inquiry
Purity:
≥98%
Appearance:
Off-white Solid
Synonyms:
CC5013; CC-5013; CC 5013; IMiD1; Lenalidomide; US brand name: Revlimid. 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
Storage:
-20°C
MSDS:
Inquire
Shelf Life:
2 years
Melting Point:
>250ºC (dec.)
InChIKey:
GOTYRUGSSMKFNF-UHFFFAOYSA-N
InChI:
InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
Canonical SMILES:
C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
1.Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, Di Bacco A, Hui AM, van de Vel N Engl J Med. 2016 Apr 28;374(17):1621-34. doi: 10.1056/NEJMoa1516282.
BACKGROUND: Ixazomib is an oral proteasome inhibitor that is currently being studied for the treatment of multiple myeloma.
2.A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome.
Cherian MA1, Tibes R2, Gao F3, Fletcher T1, Fiala M1, Uy GL1, Westervelt P1, Jacoby MA1, Cashen AF1, Stockerl-Goldstein K1, DiPersio JF1, Vij R1. Leuk Lymphoma. 2016 Apr 27:1-6. [Epub ahead of print]
Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by bone marrow failure which frequently progress to acute myeloid leukemia. Patients who fail to respond to, or progress on first-line DNA hypomethylating agents (HMA) have a poor prognosis. Conventionally dosed lenalidomide has activity in 5q-MDS. In other subtypes, it may reduce RBC transfusion requirements but does not result in cytogenetic responses. We previously reported that high-dose lenalidomide induction (50 mg/day) results in complete remissions in a high fraction of patients. We, therefore, conducted a Phase 2 trial of the same regimen in MDS refractory to HMA. Marrow complete remissions were seen in 33% of patients and hematological improvement in 8% of patients. Significant infections complicated more than 50% of cases. Future trials to explore alternative dosing schedules of high-dose lenalidomide to increase efficacy while decreasing toxicity are warranted.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PROTAC Products


CAS 2064292-52-8 VH 032 Linker 2

VH 032 Linker 2
(CAS: 2064292-52-8)

VH 032 Linker 2 is a precursor of VHL ligand for PROTAC technology, which is composed of the von Hippel-Lindau (VHL) ligand domain and the polyethylene glycol (...

CAS 1061605-21-7 TC E3 5031

TC E3 5031
(CAS: 1061605-21-7)

TC E3 5031 is a cereblon-recruiting ligand consisting of an E3 ubiquitin ligase thalidomide conjugated to a carboxylic acid linker ready for a target protein li...

CAS 191732-72-6 Lenalidomide

Lenalidomide
(CAS: 191732-72-6)

Lenalidomide is an analog of thalidomide, a TNF-α production inhibitor. Lenalidomide can be utilized in PROTAC as an E3 ligase ligand for targeting cereblon, in...

CAS 13419-46-0 DCVC

DCVC
(CAS: 13419-46-0)

DCVC has been found to influence sort of cytokines release stimulated by pathogen.

PROTAC_ERRα

PROTAC_ERRα is a VHL-based PROTAC targeting estrogen-related receptor alpha (ERRα) for degradation. ERRα plays central roles in the regulation of cellular energ...

Pomalidomide-C6-PEG3-butyl azide

Pomalidomide-C6-PEG3-butyl azide is a crosslinker-E3 ligase ligand conjugate consisting of an E3 ligase ligand pomalidomide and a PEGylated crosslinker with ter...

CAS 852391-15-2 Necrostatin 2 racemate

Necrostatin 2 racemate
(CAS: 852391-15-2)

Necrostatin 2 racemate is the racemate of Necrostatin, which is a potent necroptosis inhibitor.

CAS 4311-88-0 Necrostatin-1

Necrostatin-1
(CAS: 4311-88-0)

Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM.

Chemical Structure

CAS 191732-72-6 Lenalidomide

Quick Inquiry

Verification code

Featured Items